Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Merkel cell polyomavirus-specific and CD39+CLA+ CD8 T cells as blood-based predictive biomarkers for PD-1 blockade in Merkel cell carcinoma.
Ryu H, Bi TM, Pulliam TH, Sarkar K, Church CD, Kumar N, Mayer-Blackwell K, Jani S, Ramchurren N, Hansen UK, Hadrup SR, Fling SP, Koelle DM, Nghiem P, Newell EW. Ryu H, et al. Among authors: hadrup sr. Cell Rep Med. 2024 Feb 20;5(2):101390. doi: 10.1016/j.xcrm.2023.101390. Epub 2024 Feb 9. Cell Rep Med. 2024. PMID: 38340724 Free PMC article.
DNA based neoepitope vaccination induces tumor control in syngeneic mouse models.
Viborg N, Pavlidis MA, Barrio-Calvo M, Friis S, Trolle T, Sørensen AB, Thygesen CB, Kofoed SV, Kleine-Kohlbrecher D, Hadrup SR, Rønø B. Viborg N, et al. Among authors: hadrup sr. NPJ Vaccines. 2023 May 27;8(1):77. doi: 10.1038/s41541-023-00671-5. NPJ Vaccines. 2023. PMID: 37244905 Free PMC article.
DNA barcoded peptide-MHC multimers to measure and monitor minor histocompatibility antigen-specific T cells after allogeneic stem cell transplantation.
Fuchs KJ, Göransson M, Kester MGD, Ettienne NW, van de Meent M, de Jong RCM, Koster EAS, Halkes CJM, Scheeren F, Heemskerk MHM, van Balen P, Falkenburg JHF, Hadrup SR, Griffioen M. Fuchs KJ, et al. Among authors: hadrup sr. J Immunother Cancer. 2024 Dec 9;12(12):e009564. doi: 10.1136/jitc-2024-009564. J Immunother Cancer. 2024. PMID: 39653555 Free PMC article.
A modular protein language modelling approach to immunogenicity prediction.
O'Brien H, Salm M, Morton LT, Szukszto M, O'Farrell F, Boulton C, King L, Bola SK, Becker PD, Craig A, Nielsen M, Samuels Y, Swanton C, Mansour MR, Hadrup SR, Quezada SA. O'Brien H, et al. Among authors: hadrup sr. PLoS Comput Biol. 2024 Nov 11;20(11):e1012511. doi: 10.1371/journal.pcbi.1012511. eCollection 2024 Nov. PLoS Comput Biol. 2024. PMID: 39527593 Free PMC article.
Corrigendum: Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes.
Hulen TM, Friese C, Kristensen NP, Granhøj JS, Borch TH, Peeters MJW, Donia M, Andersen MH, Hadrup SR, Svane IM, Met Ö. Hulen TM, et al. Among authors: hadrup sr. Front Immunol. 2024 Jul 18;15:1462081. doi: 10.3389/fimmu.2024.1462081. eCollection 2024. Front Immunol. 2024. PMID: 39091496 Free PMC article.
Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways.
Skadborg SK, Maarup S, Draghi A, Borch A, Hendriksen S, Mundt F, Pedersen V, Mann M, Christensen IJ, Skjøth-Ramussen J, Yde CW, Kristensen BW, Poulsen HS, Hasselbalch B, Svane IM, Lassen U, Hadrup SR. Skadborg SK, et al. Among authors: hadrup sr. Cancer Immunol Res. 2024 Sep 3;12(9):1202-1220. doi: 10.1158/2326-6066.CIR-23-0959. Cancer Immunol Res. 2024. PMID: 38885356 Free PMC article.
Dose escalation study of a personalized peptide-based neoantigen vaccine (EVX-01) in patients with metastatic melanoma.
Mørk SK, Skadborg SK, Albieri B, Draghi A, Bol K, Kadivar M, Westergaard MCW, Stoltenborg Granhøj J, Borch A, Petersen NV, Thuesen N, Rasmussen IS, Andreasen LV, Dohn RB, Yde CW, Noergaard N, Lorentzen T, Soerensen AB, Kleine-Kohlbrecher D, Jespersen A, Christensen D, Kringelum J, Donia M, Hadrup SR, Marie Svane I. Mørk SK, et al. Among authors: hadrup sr. J Immunother Cancer. 2024 May 23;12(5):e008817. doi: 10.1136/jitc-2024-008817. J Immunother Cancer. 2024. PMID: 38782542 Free PMC article.
IMPROVE: a feature model to predict neoepitope immunogenicity through broad-scale validation of T-cell recognition.
Borch A, Carri I, Reynisson B, Alvarez HMG, Munk KK, Montemurro A, Kristensen NP, Tvingsholm SA, Holm JS, Heeke C, Moss KH, Hansen UK, Schaap-Johansen AL, Bagger FO, de Lima VAB, Rohrberg KS, Funt SA, Donia M, Svane IM, Lassen U, Barra C, Nielsen M, Hadrup SR. Borch A, et al. Among authors: hadrup sr. Front Immunol. 2024 Apr 3;15:1360281. doi: 10.3389/fimmu.2024.1360281. eCollection 2024. Front Immunol. 2024. PMID: 38633261 Free PMC article.
113 results